2025 Traceability Seminar

Speakers

Ameer Ali

Sr. Director, Manufacturer Operations & Data Services

Cencora, Inc.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Ameer Ali

Sr. Director, Manufacturer Operations & Data Services

Cencora, Inc.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Ameer Ali is Sr. Director of Manufacturer Operations at Cencora. He joined Cencora in 2015 to support DSCSA related process implementations with responsibilities spanning both data exchange and barcode compliance as well as other non-DSCSA EDI and packaging functions. He participates regularly in industry groups to support process efficiency and best practices across the supply chain. These groups include HDA DSCSA exceptions, HDA Research Foundation, GS1 Rx Secure Supply Chain and GS1 GLN workgroups among others. He also took part in many industry pilots and FDA public meetings in preparation for phased implementation of DSCSA.
Ilisa B.G. Bernstein

President

Bernstein Rx Solutions, LLC
Ilisa B.G. Bernstein

President

Bernstein Rx Solutions, LLC
Ilisa Bernstein, PharmD, JD, FAPhA, is President of Bernstein Rx Solutions, LLC, assisting clients in understanding and maneuvering through drug and pharmacy regulatory policy and compliance issues, strategies, and advocacy. She brings over 35 years of experience and expertise in the government, non-profit, and private sectors in achieving successful outcomes and advancing innovation.

Dr. Bernstein spent nearly 5 years at the American Pharmacists Association (APhA). For 13 months, she served as the 14th CEO and Executive Vice President of APhA, the first woman to lead as CEO in the 172-year history of the association. She led all operations and strategies for APhA, the Board of Pharmacy Specialties, and the APhA Foundation. She joined APhA in 2019 as Senior Vice President for Pharmacy Practice & Government Affairs and guided APhA as the voice of pharmacists in all practice settings.

For over 30 years, Dr. Bernstein held several senior leadership positions at the U.S. Food and Drug Administration (FDA). Notably, she was deputy director of FDA’s Office of Compliance in the Center for Drug Evaluation & Research, leading policies, compliance, and enforcement for drugs and for 19 years she had several senior policy advisor roles in the Office of the Commissioner. She started at FDA as a clinical pharmacology reviewer.
Recognized for her achievements, she proudly received the 2023 Distinguished Alumni Lifetime Achievement Award from the University of Michigan College of Pharmacy and was chosen as one of the 2023 Top 50 Most Influential Leaders in Pharmacy.

Dr. Bernstein was also senior associate director of worldwide regulatory affairs at Pfizer and completed a post-doctoral clinical residency at the National Institutes of Health. She earned her Doctor of Pharmacy from the University of Michigan College of Pharmacy and her Juris Doctor from American University Washington College of Law.
Alexandra Blasi

Executive Secretary

Kansas Board of Pharmacy
- Board of Pharmacy Perspectives on DSCSA Enforcement
- GLP-1 Investigations: What It Means for the Supply Chain
Alexandra Blasi

Executive Secretary

Kansas Board of Pharmacy
- Board of Pharmacy Perspectives on DSCSA Enforcement
- GLP-1 Investigations: What It Means for the Supply Chain
Alexandra Blasi is a JD and MBA graduate of Washburn University in Topeka, Kansas, and has a certificate in Business and Transactions. She was a recipient of the 2018 Graduate of the Last Decade (GOLD) Award. She is an attorney licensed in the State of Kansas and worked for the state in such capacity for several years before joining the Kansas State Board of Pharmacy as Executive Secretary in November 2015. Ms. Blasi has provided counsel to the Kansas Real Estate Commission, Board of Cosmetology, Department of Commerce, Athletic Commission, State Workforce Board, and Creative Arts Industries Commission. Ms. Blasi has served on the Kansas Information Technology Council, the Employee Advisory Committee to the Kansas Healthcare Commission, and is a current and founding member of Kansas WISE – Women in State Employment. Ms. Blasi is Chair of the PMP Interconnect Steering Committee, previously served as Chair of the Legislation and Policy Subcommittee, and was appointed to the National Association of Boards of Pharmacy Committee on Law Enforcement/Legislation beginning in 2020. In May 2023, she was presented with the John F. Atkinson Service Award by the National Association of Boards of Pharmacy.
Ian Cannell

Business Process Consultant / DSCSA National Project Sponsor

Kaiser Permanente
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
  Tuesday, August 5, 2025 | 11:20—12:20 PM
  
  Potomac Ballroom
Ian Cannell

Business Process Consultant / DSCSA National Project Sponsor

Kaiser Permanente
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
  Tuesday, August 5, 2025 | 11:20—12:20 PM
  
  Potomac Ballroom
Ian Cannell proudly represents Kaiser Permanente and continues to lead DSCSA readiness efforts across the Program.
With more than 25 years of healthcare, systems and patient case management experience, he is implementing a standardized, robust and cost-effective solution to keep Kaiser Permanente compliant in 2025 and beyond.
Riya Cao

CEO

LSPedia
- DSCSA Roundtable Discussions
  Tuesday, August 5, 2025 | 1:45—3:00 PM
  
  Meeting Room Level
Riya Cao

CEO

LSPedia
- DSCSA Roundtable Discussions
  Tuesday, August 5, 2025 | 1:45—3:00 PM
  
  Meeting Room Level
OVERALL EXPERIENCE
Riya Cao is an award-winning executive with 25 years of distinguished experience across technology, pharmaceuticals, healthcare, and government sectors. Specializing in advancing traceability and supply chain management, she excels in cost-effective compliance, operational automation, and big data analytics.
Renowned for her impactful DSCSA and serialization-focused blogs, Riya's insights are highly sought-after by 10,000+ professionals seeking regulatory clarity and best industry practices.
PROFESSIONAL EXPERTISE
As an Inc-5000 CEO, Riya is the visionary founder and leader of LSPedia, a global trailblazer in traceability solutions and Supply Chain Cloud. LSPedia serves manufacturers, wholesale distributors, 3PLs, health systems, and retail stores. Before pioneering LSPedia, Riya held the position of Head of Life Science at QAD and
various leadership roles at Ferndale Labs, TRW, and United Technologies.
Riya Cao earned her Bachelor of Science degree from Michigan Technological University.
Patrick Carroll

Consultant

Tarplin, Downs and Young, LLC
- HHS and FDA in Transition: Agency Direction and Priorities Under the New Administration
  Wednesday, August 6, 2025 | 9:30—10:30 AM
  
  Potomac Ballroom
Patrick Carroll

Consultant

Tarplin, Downs and Young, LLC
- HHS and FDA in Transition: Agency Direction and Priorities Under the New Administration
  Wednesday, August 6, 2025 | 9:30—10:30 AM
  
  Potomac Ballroom
Patrick joined TDY after spending more than 20 years serving in senior health care roles on Capitol Hill. He most recently spent 9 years with the Senate Appropriations Committee, Subcommittee on Agriculture, Rural Development and FDA, serving as the subject matter expert on all issues relating to FDA. Patrick played a pivotal role in overseeing the agency’s budget management and program implementation to ensure alignment with Congressional goals, which required bicameral negotiation and coordination with senior FDA leadership. During his tenure, FDA saw a significant increase in both budget authority and regulatory responsibilities, particularly regarding the regulation of advanced medical products and the implementation of new initiatives to expedite the drug approval process. Patrick’s expertise in FDA policy and operations has made him a trusted partner at the highest levels of
both Congress and the Executive branch. Prior to his long tenure with the Senate Appropriations Committee, Patrick worked in a senior staff capacity for Representative Ray LaHood (R-IL) and Kevin Yoder (R-KS), both influential
members of the House Appropriations Committee. He also served as Director of Federal Government Relations for the Biotechnology Industry Association (BIO), advocating on behalf of the industry with members of Congress and federal agencies on healthcare, agriculture and energy policy.
Adam Daniels

Director, Product Management

GS1 US
- DSCSA Roundtable Discussions
  Tuesday, August 5, 2025 | 1:45—3:00 PM
  
  Meeting Room Level
Adam Daniels

Director, Product Management

GS1 US
- DSCSA Roundtable Discussions
  Tuesday, August 5, 2025 | 1:45—3:00 PM
  
  Meeting Room Level
Adam Daniels is Director of Product Management at GS1 US, where he leads strategy for GS1 US Data Hub® Location and drives adoption of Global Location Numbers (GLNs) to improve data quality and traceability across supply chains. With six years of product management experience spanning healthcare and retail, he brings a data-driven, outcomes-focused approach to solving industry challenges. Adam holds a Masters in Information Systems and an MBA from the University of Cincinnati.
Libby Dewey

Manager, DSCSA

Cardinal Health, Inc.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Libby Dewey

Manager, DSCSA

Cardinal Health, Inc.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Perry L. Fri

Chief Industry Relations Officer and President, HDA Research Foundation

Healthcare Distribution Alliance
- Opening Remarks
  Tuesday, August 5, 2025 | 8:30—8:45 AM
  
  Potomac Ballroom
Perry L. Fri

Chief Industry Relations Officer and President, HDA Research Foundation

Healthcare Distribution Alliance
- Opening Remarks
  Tuesday, August 5, 2025 | 8:30—8:45 AM
  
  Potomac Ballroom
Perry L. Fri is HDA’s Chief Industry Relations Officer and President of the HDA Research Foundation. At HDA, Fri is responsible for engaging with members to ensure their connection with the association through networking, research, education, and active work on committees addressing relevant supply chain issues related to technology, operations and security. Fri currently serves on the Board of Directors for Healthcare Ready, a 501(c)(3) organization established to help public and private sector stakeholders across the pharmaceutical supply chain prepare for (and maintain operations during) disasters.

Fri previously served as Vice President of Industry Relations and Program Development for the Health Industry Distributors Association (HIDA). Prior to joining HIDA, Fri held positions with The Hale Group and Instill Corporation. He holds a BA in History from the University of Maryland.
Eric Griffin

Director of Compliance and Enforcement

Ohio State Board of Pharmacy
- GLP-1 Investigations: What It Means for the Supply Chain
  Wednesday, August 6, 2025 | 8:30—9:30 AM
  
  Potomac Ballroom
Eric Griffin

Director of Compliance and Enforcement

Ohio State Board of Pharmacy
- GLP-1 Investigations: What It Means for the Supply Chain
  Wednesday, August 6, 2025 | 8:30—9:30 AM
  
  Potomac Ballroom
Ilir Ivezaj

Senior Product

LSPedia
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Ilir Ivezaj

Senior Product

LSPedia
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Mark Karhoff

Principal Consultant, Founder

Ten Count Consulting
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Mark Karhoff

Principal Consultant, Founder

Ten Count Consulting
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Mark Karhoff is a Supply Chain & DSCSA Consultant currently working on the DSCSA and other US pharma initiatives. Mark is the founder of Ten Count Consulting, LLC with 30 years of experience in program management, transformation and supply chain solutions. Ten Count assists clients on ensuring compliance with DSCSA including readiness assessments and fractional support. He has served as a client representative on industry groups with HDA, NABP, GS1, PDG, and others to establish standards and build industry alignment.
John Kirtley

Executive Director

Arkansas State Board of Pharmacy
- Board of Pharmacy Perspectives on DSCSA Enforcement
- GLP-1 Investigations: What It Means for the Supply Chain
John Kirtley

Executive Director

Arkansas State Board of Pharmacy
- Board of Pharmacy Perspectives on DSCSA Enforcement
- GLP-1 Investigations: What It Means for the Supply Chain
John Clay Kirtley, Pharm.D., a native of Camden, completed his pre-pharmacy coursework at Ouachita Baptist University before graduating from the UAMS College of Pharmacy with his Doctor of Pharmacy. John currently serves as the Executive Director of the Arkansas State Board of Pharmacy and is a member and Past President of the Accreditation Council for Pharmacy Education’s Board of Directors and the President of MALTAGON, a Professional Association of Boards of Pharmacy.

John and his wife Melanie, who is also a pharmacist, live in Little Rock and have two children, Allison and Jack.
Blair Korman

Sr. Director, Digital Identification & Traceability

Johnson & Johnson Supply Chain
- DSCSA Roundtable Discussions
  Tuesday, August 5, 2025 | 1:45—3:00 PM
  
  Meeting Room Level
Blair Korman

Sr. Director, Digital Identification & Traceability

Johnson & Johnson Supply Chain
- DSCSA Roundtable Discussions
  Tuesday, August 5, 2025 | 1:45—3:00 PM
  
  Meeting Room Level
Blair Korman is the Senior Director of Digital Identification & Traceability for Johnson & Johnson. She leads the delivery of critical enterprise capabilities in the areas of regulatory compliance, customer compliance, standards and emerging digital technologies. She focuses her efforts on uniting the digital thread with the physical product and providing easier access to more accurate and more timely product data. Blair has more than two decades of supply chain expertise spanning operations, customer engagement and interactions with regulatory agencies and industry associations. She holds a Bachelor of Science in industrial and systems engineering from Virginia Tech and a Master of Science in engineering management from the University of South Florida.
Abha Kundi

Counsel

ArentFox Schiff LLP
- The Next Phase of DSCSA Traceability
  Tuesday, August 5, 2025 | 8:45—9:45 AM
  
  Potomac Ballroom
Abha Kundi

Counsel

ArentFox Schiff LLP
- The Next Phase of DSCSA Traceability
  Tuesday, August 5, 2025 | 8:45—9:45 AM
  
  Potomac Ballroom
Abha Kundi recently joined ArentFox Schiff as Counsel after nearly 15 years in FDA’s Office of Compliance. As Team Lead in the Office of Drug Security, Integrity & Response within the Office of Compliance, FDA’s Center for Drug Evaluation and Research, Abha developed and oversaw the Drug Supply Chain Security Act (DSCSA) program, leading a multidisciplinary team of lawyers, regulatory affairs specialists, and medical experts responsible for regulatory oversight of the pharmaceutical supply chain.

At ArentFox Schiff, Abha draws on her firsthand perspective into federal regulations to advise pharmaceutical clients on FDA compliance and enforcement matters spanning drug product quality, incident, recall, and shortage strategy, import and export compliance, supply chain security, distribution practices, and manufacturing issues.
Justin Macy

Director of Innovation

National Association of Boards of Pharmacy®
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
  Tuesday, August 5, 2025 | 11:20—12:20 PM
  
  Potomac Ballroom
Justin Macy

Director of Innovation

National Association of Boards of Pharmacy®
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
  Tuesday, August 5, 2025 | 11:20—12:20 PM
  
  Potomac Ballroom
Justin specializes in the intersection of law, technology, and healthcare with a focus on pharmacy practice and drug regulation. Recently, Justin helped lead NABP’s DSCSA efforts to support regulators, dispensers, and other trading partners by providing tools and education which enable implementation of DSCSA’s interoperability milestone (Pulse by NABP). Historically, Justin has worked closely with NABP's Digital Health team. Prior to joining NABP, Justin was a specialist in Amazon’s Consumer Legal Department and Associate Director of Innovation for a tech start-up.
Shiv Mahendran

Associate Director, Logistics and Inventory Management

Apotex Corp.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Shiv Mahendran

Associate Director, Logistics and Inventory Management

Apotex Corp.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Julie Malone

Regulatory Affairs Manager

Value Drug Company
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Julie Malone

Regulatory Affairs Manager

Value Drug Company
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Julie Malone is the Regulatory Affairs Manager for Value Drug Company where she has been a part of the DSCSA team for over ten years. In her role at VDC, she developed a regulatory affairs program across departments and additionally developed the DSCSA suspect and illegitimate product investigation system. A proven risk manager and ethical strategist, Julie has maintained VDC’s accreditation status through the NABP Drug Distributor program. With the ability to synthesize complex policy and high velocity issues Julie has contributed to compliant business operations and profitability. She has been an active member at HDA serving on several committees including the Technology Implementation Work Group. Additionally, she has public sector budget, legislative and regulatory experience. Julie holds a master’s degree in journalism from Regent University and a Bachelor of Science degree in Political Science from Carnegie Mellon University.
David G. Mason

Director of Supply Chain Compliance

Novartis Pharmaceuticals Corporation
- Barcodes and Data Quality
- Preparing for Traceability-Focused FDA Inspections: What To Expect and How To Respond
David G. Mason

Director of Supply Chain Compliance

Novartis Pharmaceuticals Corporation
- Barcodes and Data Quality
- Preparing for Traceability-Focused FDA Inspections: What To Expect and How To Respond
Dave Mason is currently the Director of Supply Chain compliance and Serialization – Dave supports the Commercial Trade and Supply Chain teams, supporting the implementation of DSCSA for the Novartis group. Leading efforts to assure Novartis error rates are six sigman or less by assuring procedures are in place for serialization data quality and integrity, improving existing serialization processes and systems as information is provided by supply chain partners on the DSCSA processes. Dave represents Novartis in trade association, PDG and FDA public meetings. He communicates to the NTO Global Serialization team with new and existing requirements for other countries, and he assures that the validation approach is consistent within the organization and execution at the sites. Dave also supports the team to develop to support serialization as it is integrated into the normal business processes. Dave has worked on serialization since 2003 in California and helped implement global solutions.
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- EPCIS Data File Timeliness and Accuracy
  Tuesday, August 5, 2025 | 10:15—11:15 AM
  
  Potomac Ballroom
Mike’s responsibilities include developing and implementing strategies to enhance patient safety and further secure the U.S. pharmaceutical supply chain. He represents Pfizer externally on various customer engagements and industry interactions related to channel security and works closely with internal Pfizer colleagues to implement approved strategies. Mike has been directly involved with Pfizer’s global projects to implement serialization and is responsible for ensuring compliance with the U.S. Drug Supply Chain Security Act (DSCSA) requirements. He also works closely with Pfizer’s Global Security organization as it relates to investigations of suspected counterfeit or adulterated Pfizer products and is an active member of GS1 US Healthcare, Pharmaceutical Distribution Security Alliance (PDSA) and the Partnership for DSCSA Governance (PDG). Mike has worked within the pharmaceutical industry for over 31 years with most of that time spent in trade operations at Pfizer.
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- EPCIS Data File Timeliness and Accuracy
- DSCSA Roundtable Discussions
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- EPCIS Data File Timeliness and Accuracy
- DSCSA Roundtable Discussions
Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability. Scott leads McKesson’s Traceability Team working on implementation across McKesson’s various business units.

Scott joined McKesson in 1987 and had previous roles in Finance, Distribution Center Management and as a Regional Vice President of Distribution Operations. Scott has participated in McKesson’s integration of acquisitions over the last 16 years.

Scott has been active in HDA’s Traceability Workgroup, the HDA Industry Relations Council and participates in several committees including the FGAC, RAC and SGAC. He is tri-chair of GS1 Global Healthcare Leadership Team and is a member of the GS1 US Healthcare Executive Leadership Committee. Scott is serving as a member of the Board of Directors of the Partnership for DSCSA Governance as well.

Scott has a BA in Accountancy and a MBA from the University of Wisconsin – La Crosse.
Sean Murphy

Manager, Manufacturer Operations

Cencora, Inc.
- Barcodes and Data Quality
  Wednesday, August 6, 2025 | 10:30—11:00 AM
  
  Potomac Ballroom
Sean Murphy

Manager, Manufacturer Operations

Cencora, Inc.
- Barcodes and Data Quality
  Wednesday, August 6, 2025 | 10:30—11:00 AM
  
  Potomac Ballroom
Sean Murphy has been with Cencora, a global leader in pharmaceutical solutions, for over 10 years. He started in Replenishment Operations where he focused on demand planning and analytics. For the past seven years Sean has worked on implementation of the Drug Supply Chain Security Act (DSCSA) helping to ensure compliance and improve traceability within the pharmaceutical supply chain.
Sean brings a practical understanding of supply chain operations and regulatory requirements with a focus on implementing solutions that enhance efficiency and support industry standards.
Angela Nelson

DSCSA

CVS Health
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
  Tuesday, August 5, 2025 | 11:20—12:20 PM
  
  Potomac Ballroom
Angela Nelson

DSCSA

CVS Health
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
  Tuesday, August 5, 2025 | 11:20—12:20 PM
  
  Potomac Ballroom
Angela Nelson is a seasoned healthcare and operations leader with over 35 years of experience at CVS. A licensed pharmacist by training, Angela brings a unique blend of clinical insight and operational expertise to her role as Executive Director of Systems, Technology, and Compliance. She has been a key leader in the enterprise-wide implementation of the Drug Supply Chain Security Act (DSCSA), ensuring regulatory readiness and operational excellence across the organization. Angela leads initiatives that enhance supply chain performance, drive innovation, and uphold the highest standards of compliance. Angela is known for her ability to inspire trust foster cross-functional collaboration, and deliver technology-enabled solutions that improve efficiency, safety, and customer experience.
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
- DSCSA Roundtable Discussions
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
- DSCSA Roundtable Discussions
Leon Nevers is the Director of Procurement and Business Development with H-E-B Pharmacy. Leon has been engaged in retail buying and selling for a lifetime. He actively works with suppliers, employers, state and U.S. political leaders, and a variety of health care providers to provide lifestyle changes that keep Texans healthy at H-E-B.

Leon has managed direct relationships with hundreds of H-E-B suppliers of Rx, OTC, and Home Diagnostics controlling an annual budget of over $2 billion per year. He currently is Chairman of The Buyers Consortium, LLC, representing 1200 retail stores and $1 billion in Generics Purchasing opportunity with group contracting. He directs, trains, and coaches business development experts to support all aspects of procurement, immunizations, store communications, third party reimbursement, specialty pharmacy, medication therapy management and helps form strategies for business development and buying.

With extensive experience in both the pharmacy and retail industries, Leon looks for simple solutions that can make life long health improvements in a value market. He believes in serving others as a formula for personal success.
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- VRS PN and the Journey to DSCSA Compliance
- GLP-1 Investigations: What It Means for the Supply Chain
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- VRS PN and the Journey to DSCSA Compliance
- GLP-1 Investigations: What It Means for the Supply Chain
Tish Eggleston Pahl is a principal at Olsson Frank Weeda Terman Matz PC. She is regulatory counsel to drug, cosmetic, dietary supplement and food clients with concerns before the Food and Drug Administration, the Federal Trade Commission, and other federal agencies. Her work has encompassed representation of companies making and marketing human and animal prescription and over-the-counter (OTC) drugs, foods, dietary supplements, cannabis, and cosmetics. She has particular expertise in the areas of health care communications, advertising and labeling of FDA-regulated products. Further, she advises trade association clients on a range of antitrust and trade regulation issues.

Since November 2013, Tish has been heavily involved with implementation of the Drug Supply Chain Security Act (DSCSA). She has worked closely with pharmaceutical supply chain stakeholders, including manufacturers,
repackagers, and wholesale distributors, on implementation of the DSCSA and is a frequent speaker on the law’s implementation.

Tish is a regular participant in HDA's Traceability Implementation Work Group and the Verification Router Service.

Tish graduated from Northwestern University and earned her Juris Doctor from Northwestern University (cum laude).
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- VRS PN and the Journey to DSCSA Compliance
  Tuesday, August 5, 2025 | 4:30—5:30 PM
  
  Potomac Ballroom
Christopher A. Reed

VP, Quality and Regulatory Operations, U.S. Supply Chain

Cencora, Inc.
- Preparing for Traceability-Focused FDA Inspections: What To Expect and How To Respond
  Wednesday, August 6, 2025 | 11:00—12:00 PM
  
  Potomac Ballroom
Christopher A. Reed

VP, Quality and Regulatory Operations, U.S. Supply Chain

Cencora, Inc.
- Preparing for Traceability-Focused FDA Inspections: What To Expect and How To Respond
  Wednesday, August 6, 2025 | 11:00—12:00 PM
  
  Potomac Ballroom
Christopher Reed currently serves as VP, Quality and Regulatory Operations, U.S. Supply Chain.
Chris is responsible for implementing and sustaining quality standards as well as regulatory requirements for Cencora’s U.S. Supply Chain. In his role, Chris ensures compliance with federal, state, local regulations while partnering with upstream and downstream customers to enable compliance-based solutions.
Previously, Chris worked for KPMG US, LP where he served his clients as a Manager, Management Consulting. His focus was Life Science Advisory, specifically strategy and implementation related to complex regulatory requirements. Before that, Chris held several roles of increasing responsibility across Johnson & Johnson’s global supply chain focused on serialization of pharmaceutical drugs, supply chain standards, and master data.
Chris graduated from Rowan University with a Bachelor of Arts, Law and Justice.
Kala Shankle

Vice President, Regulatory Affairs

Healthcare Distribution Alliance
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
- DSCSA Roundtable Discussions
Kala Shankle

Vice President, Regulatory Affairs

Healthcare Distribution Alliance
- Dispenser Perspectives: DSCSA Readiness, Challenges and Next Steps
- DSCSA Roundtable Discussions
Kala Shankle is Vice President of Regulatory Affairs. In this role, Shankle leads HDA’s regulatory activities and engagement for members’ priority issues.

Prior to joining HDA, Shankle was an attorney at Epstein, Becker and Green, where she counseled pharmaceutical supply chain stakeholders on regulatory and compliance matters. Previously, Shankle provided legal counsel, developed policy solutions and led regulatory engagement for the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA) and a state pharmacy association in Florida.

She received both her Juris Doctor and Bachelor of Science from Florida State University. She is a Board member for the American Society for Pharmacy Law.
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
- EPCIS Data File Timeliness and Accuracy
- DSCSA Roundtable Discussions
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
- EPCIS Data File Timeliness and Accuracy
- DSCSA Roundtable Discussions
Tim Stearns is a Senior E-Commerce Analyst with Baxter HealthCare, focusing primarily on the distributor customer base. With over 22 years of experience in information systems, he has integrated back–end systems and implemented numerous EDI transaction sets focused on contract/chargeback administration, customer credit and invoicing, returns processing, order management and shipping notices, track–and–trace /pedigree systems design, customer–to–HIN alignment with HIBCC and distributor Fee for Service/inventory management agreements. Tim has served twice as co–chair of the HDMA Business Technology Committee, member of the HDMA eCommerce Task Force, member of the CSOS Working Group and the Health Industry Business Communications Council E-Business Council.
Jenni Wai

Chief Pharmacist

Ohio State Board of Pharmacy
- Board of Pharmacy Perspectives on DSCSA Enforcement
  Tuesday, August 5, 2025 | 3:30—4:30 PM
  
  Potomac Ballroom
Jenni Wai

Chief Pharmacist

Ohio State Board of Pharmacy
- Board of Pharmacy Perspectives on DSCSA Enforcement
  Tuesday, August 5, 2025 | 3:30—4:30 PM
  
  Potomac Ballroom

We use cookies, pixels and other technology to understand our users better and ensure that we give you the best experience on our website.

2025 Traceability Seminar

August 4-6, 2025 | The Westin DC Downtown

2025 Traceability Seminar

August 4-6, 2025 | The Westin DC Downtown

Speakers

Ameer Ali

Ameer Ali

Ilisa B.G. Bernstein

Ilisa B.G. Bernstein

Alexandra Blasi

Alexandra Blasi

Ian Cannell

Ian Cannell

Riya Cao

Riya Cao

Patrick Carroll

Patrick Carroll

Adam Daniels

Adam Daniels

Libby Dewey

Libby Dewey

Perry L. Fri

Perry L. Fri

Eric Griffin

Eric Griffin

Ilir Ivezaj

Ilir Ivezaj

Mark Karhoff

Mark Karhoff

John Kirtley

John Kirtley

Blair Korman

Blair Korman

Abha Kundi

Abha Kundi

Justin Macy

Justin Macy

Shiv Mahendran

Shiv Mahendran

Julie Malone

Julie Malone

David G. Mason

David G. Mason

Michael J. Mazur

Michael J. Mazur

Scott A. Mooney

Scott A. Mooney

Sean Murphy

Sean Murphy

Angela Nelson

Angela Nelson

Leon Nevers

Leon Nevers

Tish E. Pahl

Tish E. Pahl

Jaidalyn Rand

Jaidalyn Rand

Christopher A. Reed

Christopher A. Reed

Kala Shankle

Kala Shankle

Tim Stearns

Tim Stearns

Jenni Wai

Jenni Wai